Publications by authors named "A Vazeou"
Aim: To conduct a systematic review with meta-analysis to provide a comprehensive synthesis of randomized controlled trials (RCTs) and prospective cohort studies investigating the effects of currently available bolus advisors on glycaemic parameters in adults with diabetes.
Materials And Methods: An electronic search of PubMed, Embase, CINAHL, Cochrane Library and ClinicalTrials.gov was conducted in December 2022.
Increased variability of glucose (GV) and blood pressure (BPV) is linked to a higher risk of macro- and microvascular complications and other hard endpoints. This scoping review aims to summarize the existing evidence regarding the association between the parameters of the blood pressure (BP) profile, especially BPV, with indices of short- and mid-term GV. .
View Article and Find Full Text PDFArticle Synopsis
- The study analyzed 21,634 children and adolescents with type 1 diabetes (T1D) to assess the prevalence of modifiable cardiovascular risk factors (CVRFs) like dyslipidaemia, obesity, and high HbA1c levels, and their relation to blood pressure (BP) categories.
- Hypertensive patients exhibited poorer lipid profiles, higher rates of obesity, and elevated HbA1c compared to normotensive peers, with significant percentages of hypertensive individuals having one or more CVRFs.
- The findings indicate that modifiable CVRFs are more prevalent in T1D patients with elevated BP or hypertension, highlighting obesity as the most strongly associated risk factor.
Article Synopsis
- The study investigates hypertension prevalence in children and adolescents with type 1 diabetes (T1D), finding it is notably higher compared to those without T1D.
- The analysis included over 27,000 participants, indicating that those with more frequent blood pressure measurements showed lower hypertension rates than those with fewer assessments.
- Results reveal age and gender differences in hypertension prevalence, with older adolescents and males showing higher rates, suggesting the measurement methodology influences hypertension results.
Introduction: Lipoatrophy (LA) is one of the complications of insulin treatment. It has become rare thanks to insulin analogues but it can still be observed in patients with diabetes type 1(T1DM). No effective treatment exists.
View Article and Find Full Text PDF